{"organizations": [], "uuid": "9f764947f711fd12d753aaa26bebec25a289f505", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180305.html", "section_title": "Archive News &amp; Video for Monday, 05 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-anthera-pharma-qtrly-net-loss-per/brief-anthera-pharma-qtrly-net-loss-per-share-applicable-to-common-stockholders-0-73-idUSASB0C8UW", "country": "US", "domain_rank": 408, "title": "BRIEF-Anthera Pharma Qtrly Net Loss Per Share Applicable To Common Stockholders $0.73", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.79, "site_type": "news", "published": "2018-03-06T05:21:00.000+02:00", "replies_count": 0, "uuid": "9f764947f711fd12d753aaa26bebec25a289f505"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-anthera-pharma-qtrly-net-loss-per/brief-anthera-pharma-qtrly-net-loss-per-share-applicable-to-common-stockholders-0-73-idUSASB0C8UW", "ord_in_thread": 0, "title": "BRIEF-Anthera Pharma Qtrly Net Loss Per Share Applicable To Common Stockholders $0.73", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "anthera pharmaceuticals inc", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 5 (Reuters) - Anthera Pharmaceuticals Inc:\n* ANTHERA PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND REPORTS 2017 FOURTH QUARTER AND FISCAL YEAR FINANCIAL RESULTS\n* QTRLY NET LOSS PER SHARE APPLICABLE TO COMMON STOCKHOLDERS $0.73\n* Q4 EARNINGS PER SHARE VIEW $-0.66 â€” THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-06T05:21:00.000+02:00", "crawled": "2018-03-06T22:17:58.004+02:00", "highlightTitle": ""}